ALS vs MS: Understanding the Differences and Similarities

First Warning Signs: How Early Symptoms of ALS Differ From MS

Early ALS symptoms: Muscle weakness, twitching, and speech changes typically appear first

ALS typically announces itself through localized muscle weakness in one limb or in the muscles controlling speech — not widespread decline all at once. [7] When the legs or feet are affected first (limb-onset ALS), early signs include stumbling, foot drop, or difficulty walking; when the hands and arms are involved, dropping objects or losing grip strength are common signals. [8] In [bulbar-onset ALS](https://alsunited.org/blog/understanding-bulbar-als), the muscles controlling speech and swallowing are affected first, producing slurred words, difficulty chewing, or visible twitching in the tongue. [8] Involuntary muscle twitching — fasciculations — can occur alongside or even before noticeable weakness, which is part of why early ALS symptoms are so often attributed to other conditions before a definitive diagnosis is reached. [7]

Early MS symptoms: Vision problems, numbness, and fatigue often signal onset

Does ALS get mistaken for MS? Why early misdiagnosis happens and how to avoid it
ALS does get mistaken for MS — and the reverse also occurs. Nearly 40% of people with ALS initially receive a false negative and are told they have a different condition first, while 10-15% of patients diagnosed with ALS actually have another disease entirely. [10] MS is among the most common ALS mimics, particularly in early stages when motor weakness dominates and imaging results remain inconclusive. [10] Seeking evaluation from a neurologist with specific ALS experience — as outlined in our guide on [what type of doctor treats ALS](https://alsunited.org/blog/what-type-of-doctor-treats-als) — is the most practical step toward reducing the risk of a delayed or incorrect diagnosis. [10]

Comparing Disease Progression: Timeline, Severity, and Long-Term Outlook

ALS progression: Rapid decline over 2-5 years on average; unpredictable trajectory

ALS progression follows no fixed schedule, but the CDC reports that most people live 3-5 years after symptom onset. [11] Age at onset is among the strongest predictors of trajectory: people under 65 have a median survival of 40.2 months, compared to 25.9 months for those over 65. [12] Bulbar-onset ALS — which affects the muscles controlling speech and swallowing — carries an estimated survival of fewer than 2 years from diagnosis. [12] Around 10-20% of people with ALS live beyond 10 years, and in rare cases much longer, so individual factors shape outcomes far more than population averages — our guide on [ALS life expectancy](https://alsunited.org/blog/understanding-als-life-expectancy-a-comprehensive-guide/) walks through those variables in detail. [12]

MS progression: Highly variable; some patients experience remission or slow progression

MS progression varies far more than ALS, largely because most people with MS have relapsing-remitting MS (RRMS), a form marked by episodes of worsening symptoms followed by partial or full recovery. [14] Between relapses, the condition typically remains stable, and a 60-year longitudinal study found that people with RRMS have a median life expectancy of 77.8 years — nearly on par with the general population. [14] By contrast, primary progressive MS (PPMS), which involves continuous worsening without remission periods, carries a lower median life expectancy of 71.4 years. [14] On average, MS shortens life expectancy by six to seven years, though this gap has been narrowing as disease-modifying therapies have become more effective. [13]

Comparison table: Speed of progression, typical lifespan, and quality-of-life factors

| Metric | ALS | MS |
|—|—|—|
| Speed of progression | Continuous decline, no remission | Relapsing-remitting (most common) or progressive |
| Median survival after diagnosis | 2-5 years | 30-35 years |
| Typical age of onset | 40-70 years | 20-50 years |
| Remission possible | Rare | Yes, in RRMS |
| Life expectancy impact | Fatal; significantly shortened | Shortened by ~6-7 years on average |
| Quality of life focus | Preserving motor function, speech, and breathing | Managing relapses and slowing disability progression |

The table above makes the core difference plain: ALS progresses continuously without remission, while MS allows periods of stability that can preserve long-term function for years or decades. [15] Most people with ALS face significant motor decline within 2-5 years of diagnosis, with respiratory failure as the primary cause of death, though roughly 10% live a decade or more. [16] MS most often follows a relapsing-remitting course, with an average life expectancy of 30-35 years after diagnosis — though progressive forms carry a more constrained outlook. [16] For both conditions, quality of life depends on early access to specialized care and, for ALS specifically, proactive planning around respiratory and communication support. [15]

Getting the Right Diagnosis and Building Your Support Plan

Diagnostic tests that distinguish ALS from MS: EMG, MRI, spinal fluid analysis, and genetic testing

Doctors distinguish ALS from MS using four main tests: EMG, MRI, spinal fluid analysis, and genetic testing. [17] An EMG detects denervation patterns in muscle tissue that are characteristic of ALS but absent in MS, while MRI identifies white matter lesions across the brain and spinal cord — a hallmark of MS that rarely appears in ALS. [18] Spinal fluid analysis helps exclude other conditions in both diseases, and genetic testing is relevant when familial ALS is suspected, as C9orf72 mutations are documented in inherited cases. [19] Neither condition is confirmed by a single test — ALS is primarily a [diagnosis of exclusion](https://alsunited.org/blog/symptoms-and-diagnosis), while MS requires evidence of CNS damage in at least two distinct locations at two separate points in time. [17]

Why working with an ALS specialist matters: The importance of accurate diagnosis and timely treatment

Working with a neurologist who has specific ALS experience is the most direct way to reduce the risk of misdiagnosis or delayed care. The median time from symptom onset to diagnosis is 10 to 16 months, driven largely by disease heterogeneity and limited early specialist involvement.[20] Earlier diagnosis opens access to disease-modifying treatments within their therapeutic window and improves eligibility for clinical trials — both outcomes that narrow significantly when diagnosis is delayed.[21] Misdiagnosis delays appropriate care, creates unnecessary emotional burden, and can result in treatments that worsen rather than help, making specialist referral not optional but essential.[21] We are here for you in connecting with the right care team — reaching an ALS specialist early is one of the highest-impact steps a person with suspected ALS can take.

Building your care team: How ALS United connects you with local resources, counseling, and advocacy support

An ALS diagnosis introduces not just a medical challenge but a coordination challenge — managing specialist visits, insurance approvals, equipment orders, and emotional support often all at once. [24] Coordinated multidisciplinary care, bringing together neurology, respiratory therapy, speech-language pathology, and social work in one aligned system, is the clinical standard because fragmented care creates gaps that slow or worsen outcomes. [23] Our services connect families to local clinics, counseling, advocacy programs, and [peer support groups](https://alsunited.org/blog/join-a-support-group) through a central point of contact, reducing the administrative weight that ALS places on patients and caregivers. [22] We are here for you throughout every stage of this journey — together in the fight against ALS.